| scholarly article | Q13442814 |
| P2093 | author name string | Raouf A Khalil | |
| Ossama M Reslan | |||
| P2860 | cites work | Prevalence and Trends in Obesity Among US Adults, 1999-2000 | Q22253005 |
| Endoglin is a component of the transforming growth factor-beta receptor system in human endothelial cells | Q24337230 | ||
| Maternal obesity and diabetes as risk factors for adverse pregnancy outcomes: differences among 4 racial/ethnic groups | Q24544895 | ||
| VEGF inhibition and renal thrombotic microangiopathy | Q24632792 | ||
| Correlation between oral sex and a low incidence of preeclampsia: a role for soluble HLA in seminal fluid? | Q28137967 | ||
| Eicosanoids in preeclampsia | Q28166550 | ||
| Primary, secondary, and tertiary prevention of pre-eclampsia | Q28176253 | ||
| Seminal 'priming' for protection from pre-eclampsia-a unifying hypothesis | Q28191647 | ||
| Low-molecular-weight heparin for the prevention of obstetric complications in women with thrombophilias | Q28193116 | ||
| Thrombophilia and severe preeclampsia: time to screen and treat in future pregnancies? | Q28193351 | ||
| Aspirin for prevention of preeclampsia in women with historical risk factors: a systematic review | Q28196410 | ||
| Human placental vascular development: vasculogenic and angiogenic (branching and nonbranching) transformation is regulated by vascular endothelial growth factor-A, angiopoietin-1, and angiopoietin-2 | Q28221171 | ||
| Predominant basal directional release of thromboxane, but not prostacyclin, by placental trophoblasts from normal and preeclamptic pregnancies | Q28222709 | ||
| Soluble endoglin contributes to the pathogenesis of preeclampsia | Q28244053 | ||
| Hypertension produced by placental ischemia in pregnant rats is associated with increased soluble endoglin expression | Q28573546 | ||
| Aortic adaptation to pregnancy: elevated expression of matrix metalloproteinases-2 and -3 in rat gestation | Q28574980 | ||
| Immunosuppression improves blood pressure and endothelial function in a rat model of pregnancy-induced hypertension | Q28582225 | ||
| Impaired angiogenesis in SHR is associated with decreased KDR and MT1-MMP expression | Q28582505 | ||
| Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia | Q29615916 | ||
| Hypoxia inducible factor-alpha binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein | Q29615931 | ||
| How matrix metalloproteinases regulate cell behavior | Q29620360 | ||
| Trial of Calcium to Prevent Preeclampsia | Q73485563 | ||
| Increased nitric oxide synthase activity and expression in the human uterine artery during pregnancy | Q74253964 | ||
| Enhanced vascular reactivity during inhibition of nitric oxide synthesis in pregnant rats | Q74518978 | ||
| Nitric oxide production with preeclampsia | Q74601245 | ||
| Is preeclampsia an infectious disease? | Q77153770 | ||
| Circulating levels of immunoreactive cytokines in women with preeclampsia | Q77384781 | ||
| Activation of leukocytes during the uteroplacental passage in preeclampsia | Q77513220 | ||
| Peripheral blood mononuclear cells stimulate progesterone production by luteal cells derived from pregnant and non-pregnant women: possible involvement of interleukin-4 and interleukin-10 in corpus luteum function and differentiation | Q77519168 | ||
| Tumor necrosis factor-alpha-induced hypertension in pregnant rats results in decreased renal neuronal nitric oxide synthase expression | Q77684136 | ||
| Surgically obtained sperm, and risk of gestational hypertension and pre-eclampsia | Q77731627 | ||
| Endothelin mediates renal vasodilation and hyperfiltration during pregnancy in chronically instrumented conscious rats | Q77755765 | ||
| Microalbuminuria after pregnancy complicated by pre-eclampsia | Q77799245 | ||
| Plasma and 24-h NO(x) and cGMP during normal pregnancy and preeclampsia in women on a reduced NO(x) diet | Q78009520 | ||
| Stimulated mechanisms of Ca2+ entry into vascular smooth muscle during NO synthesis inhibition in pregnant rats | Q78020557 | ||
| Nutritional interventions for the prevention of maternal morbidity | Q78171557 | ||
| Trial of prophylactic administration of TXA2 synthetase inhibitor, ozagrel hydrochloride, for preeclampsia | Q78220660 | ||
| Arachidonic acid metabolites and an early stage of pulmonary hypertension in chronically hypoxic newborn pigs | Q78396702 | ||
| Expression of estrogen receptor-alpha, estrogen receptor-beta and placental endothelial and inducible NO synthase in intrauterine growth-restricted and normal placentals | Q79255453 | ||
| Vascular matrix metalloproteinase-9 mediates the inhibition of myogenic reactivity in small arteries isolated from rats after short-term administration of relaxin | Q79278420 | ||
| Hypertension in response to autoantibodies to the angiotensin II type I receptor (AT1-AA) in pregnant rats: role of endothelin-1. | Q37447371 | ||
| Accuracy of serum uric acid as a predictive test for maternal complications in pre-eclampsia: bivariate meta-analysis and decision analysis | Q37525274 | ||
| Control of hypertension in pregnancy | Q37628832 | ||
| Levels of antibodies against cytomegalovirus and Chlamydophila pneumoniae are increased in early onset pre-eclampsia | Q37868905 | ||
| Human-specific expression of Siglec-6 in the placenta | Q38300677 | ||
| Evidence for Declining Extracellular Calcium Uptake and Protein Kinase C Activity in Uterine Arterial Smooth Muscle during Gestation in Gilts1 | Q38330292 | ||
| Effect of a low calcium intake on the vascular sensitivity to angiotensin II in normotensive pregnant rats | Q38331357 | ||
| Transcriptional stimulation of the eNOS gene by the stable prostacyclin analogue beraprost is mediated through cAMP-responsive element in vascular endothelial cells: close link between PGI2 signal and NO pathways | Q38351435 | ||
| Study of plasma adrenomedullin level in normal pregnancy and preclampsia. | Q39446260 | ||
| Decreased fractional urinary calcium excretion and serum 1,25-dihydroxyvitamin D and IGF-I levels in preeclampsia | Q79664842 | ||
| Renal angiotensin-II receptors expression changes in a model of preeclampsia | Q80238082 | ||
| Mesangial AT1/B2 receptor heterodimers contribute to angiotensin II hyperresponsiveness in experimental hypertension | Q80361560 | ||
| Serum levels of interleukin-6, interleukin-1beta and human chorionic gonadotropin in pre-eclamptic and normal pregnancy | Q80454204 | ||
| Prepregnancy diabetes and risk of placental vascular disease | Q80515997 | ||
| Recent patents on Rho signaling pathway as therapeutic target for cardiovascular diseases | Q80551190 | ||
| Circulating angiogenic factors in singleton vs multiple-gestation pregnancies | Q80564650 | ||
| ADAM12s in maternal serum as a potential marker of pre-eclampsia | Q80673251 | ||
| Adhesion molecules changes at 20 gestation weeks in pregnancies complicated by preeclampsia | Q80812036 | ||
| Serum visfatin levels in late pregnancy and pre-eclampsia | Q80999389 | ||
| Leptin, soluble leptin receptor and leptin gene polymorphism in relation to preeclampsia risk | Q81009011 | ||
| Effects of age, gender, ethnicity, diurnal variation and exercise on circulating levels of matrix metalloproteinases (MMP)-2 and -9, and their inhibitors, tissue inhibitors of matrix metalloproteinases (TIMP)-1 and -2 | Q81194988 | ||
| Generation of reactive oxygen species by neutrophils and endothelial cell injury in normal and preeclamptic pregnancies | Q81236313 | ||
| Tumor necrosis factor-alpha in the placenta is not elevated in pre-eclamptic patients despite its elevation in peripheral blood | Q81432957 | ||
| Pre-eclampsia | Q81446389 | ||
| Circulating concentrations of sFlt1 (soluble fms-like tyrosine kinase 1) in fetal and maternal serum during pre-eclampsia | Q81813556 | ||
| Dietary fiber, potassium, magnesium and calcium in relation to the risk of preeclampsia | Q81878607 | ||
| First-trimester serum levels of soluble endoglin and soluble fms-like tyrosine kinase-1 as first-trimester markers for late-onset preeclampsia | Q81931104 | ||
| Circulating angiogenic proteins in trisomy 13 | Q82150298 | ||
| Calcium supplementation for the prevention of pre-eclampsia | Q82283234 | ||
| Twin pregnancy with complete hydatidiform mole and coexistent fetus: obstetrical and oncological outcomes in a series of 14 cases | Q83296614 | ||
| Prediction of preeclampsia by analysis of cell-free messenger RNA in maternal plasma | Q83351931 | ||
| An automated method for the determination of the sFlt-1/PIGF ratio in the assessment of preeclampsia | Q84768567 | ||
| The impact of maternal obesity on maternal and fetal health | Q40007232 | ||
| Prostacyclin and thromboxane changes predating clinical onset of preeclampsia: a multicenter prospective study | Q40802999 | ||
| Preeclampsia: an excessive maternal inflammatory response to pregnancy | Q40824430 | ||
| Hyperuricemia and xanthine oxidase in preeclampsia, revisited | Q40951966 | ||
| Effect of calcium supplementation on pregnancy-induced hypertension and preeclampsia: a meta-analysis of randomized controlled trials | Q40970723 | ||
| Mechanisms of smooth muscle contraction | Q41169589 | ||
| Nitric oxide and pregnancy | Q41449537 | ||
| Postpartum renal lesions in women with pre-eclampsia | Q41682946 | ||
| Resistance artery smooth muscle function in pregnancy and preeclampsia | Q42516324 | ||
| Stabilization of hypoxia-inducible factor-1{alpha} by prostacyclin under prolonged hypoxia via reducing reactive oxygen species level in endothelial cells. | Q43413808 | ||
| Reduced uterine perfusion pressure during pregnancy in the rat is associated with increases in arterial pressure and changes in renal nitric oxide. | Q43576536 | ||
| Regulation of prostacyclin synthesis by angiotensin II and TNF-alpha in vascular smooth muscle | Q43577316 | ||
| Neutrophil activation induced by placental factors in normal and pre-eclamptic pregnancies in vitro | Q43664278 | ||
| The role of endothelium-derived hyperpolarizing factor in the regulation of the uterine circulation in pregnant rats | Q43745798 | ||
| Longitudinal study of platelet size changes in gestation and predictive power of elevated MPV in development of pre-eclampsia | Q43872581 | ||
| Important role of Rho-kinase in the pathogenesis of cardiovascular inflammation and remodeling induced by long-term blockade of nitric oxide synthesis in rats | Q43888051 | ||
| Differential mechanisms of endothelium-dependent vasodilator responses in human myometrial small arteries in normal pregnancy and pre-eclampsia | Q44048792 | ||
| Folic acid supplementation in early second trimester and the risk of preeclampsia | Q44054579 | ||
| Enhanced [Ca2+]i in renal arterial smooth muscle cells of pregnant rats with reduced uterine perfusion pressure | Q44185600 | ||
| Reduced function of endothelial prostacyclin in human omental resistance arteries in pre-eclampsia | Q44218040 | ||
| Association between 894G>T endothelial nitric oxide synthase gene polymorphisms and metabolic syndrome | Q44401791 | ||
| Pulmonary vascular endothelial growth factor and nitric oxide interaction during total cardiopulmonary bypass in neonatal pigs | Q44456864 | ||
| Tumor necrosis factor alpha in the bovine oviduct during the estrous cycle: messenger RNA expression and effect on secretion of prostaglandins, endothelin-1, and angiotensin II. | Q44475138 | ||
| Pre-eclampsia (EPH-gestosis)-induced decrease of MMP-s content in the umbilical cord artery | Q44555376 | ||
| Levels of oxidative stress and redox-related molecules in the placenta in preeclampsia and fetal growth restriction | Q44629064 | ||
| The M235T variant of the angiotensinogen gene is related to development of self-reported hypertension during pregnancy: the Prospect-EPIC cohort study | Q44632633 | ||
| Reduced endothelial NO-cGMP-mediated vascular relaxation and hypertension in IL-6-infused pregnant rats | Q44715072 | ||
| Endothelin-1 promotes Ca2+ antagonist-insensitive coronary smooth muscle contraction via activation of epsilon-protein kinase C. | Q44774841 | ||
| Interpregnancy weight change and risk of adverse pregnancy outcomes: a population-based study | Q44822507 | ||
| Maternal levels of prostacyclin, thromboxane, vitamin E, and lipid peroxides throughout normal pregnancy | Q44929423 | ||
| Inhibition of inducible nitric oxide synthase and superoxide production reduces matrix metalloproteinase-9 activity and restores coronary vasomotor function in rat cardiac allografts | Q45008785 | ||
| Activation of Rho/Rho kinase signaling pathway by reactive oxygen species in rat aorta | Q45061635 | ||
| Paternal and maternal components of the predisposition to preeclampsia | Q45084472 | ||
| A novel human-specific soluble vascular endothelial growth factor receptor 1: cell-type-specific splicing and implications to vascular endothelial growth factor homeostasis and preeclampsia | Q45143705 | ||
| Matrix metalloproteinase-specific inhibition of Ca2+ entry mechanisms of vascular contraction | Q45159052 | ||
| Effects of vasoactive agents on intracellular calcium and force in myometrial and subcutaneous resistance arteries isolated from preeclamptic, pregnant, and nonpregnant woman | Q45254319 | ||
| Investigation of vascular responses in endothelial nitric oxide synthase/cyclooxygenase-1 double-knockout mice: key role for endothelium-derived hyperpolarizing factor in the regulation of blood pressure in vivo. | Q45256231 | ||
| Plasma-mediated vascular dysfunction in the reduced uterine perfusion pressure model of preeclampsia: a microvascular characterization. | Q45947357 | ||
| Maternal ethnicity, paternal ethnicity, and parental ethnic discordance: predictors of preeclampsia. | Q45961711 | ||
| GRP78 as a marker of pre-eclampsia: an exploratory study. | Q45989281 | ||
| Insulin resistance and preeclampsia in gestational diabetes mellitus | Q46201840 | ||
| Possible gene-gene interaction of KIR2DL4 with its cognate ligand HLA-G in modulating risk for preeclampsia. | Q46333261 | ||
| Pregnancy outcome and fibrinolytic, endothelial and coagulation markers in women undergoing uterine artery Doppler screening at 23 weeks | Q46334260 | ||
| Metabolic syndrome in normal and complicated pregnancies | Q46338732 | ||
| Maternal autoantibodies from preeclamptic patients activate angiotensin receptors on human mesangial cells and induce interleukin-6 and plasminogen activator inhibitor-1 secretion | Q46344658 | ||
| Pregnancy-related mortality from preeclampsia and eclampsia | Q46353535 | ||
| Angiogenin and vascular endothelial growth factor in pregnancies complicated by preeclampsia | Q46440312 | ||
| Increased phospholipase A2 and thromboxane but not prostacyclin production by placental trophoblast cells from normal and preeclamptic pregnancies cultured under hypoxia condition | Q46454719 | ||
| Evidence that inward rectifier K+ channels mediate relaxation by the PGI2 receptor agonist cicaprost via a cyclic AMP-independent mechanism | Q46719781 | ||
| Insulin-like factor 3 levels in amniotic fluid of human male fetuses. | Q46726063 | ||
| Effect of L-arginine therapy on the glomerular injury of preeclampsia: a randomized controlled trial | Q46777480 | ||
| Proteasomal activity in placentas from women with preeclampsia and intrauterine growth restriction: implications for expression of HIF-alpha proteins | Q46789404 | ||
| Uric acid concentrations in early pregnancy among preeclamptic women with gestational hyperuricemia at delivery | Q46876317 | ||
| Women with preeclampsia have higher plasma endothelin levels than women with normal pregnancies | Q46878600 | ||
| Endothelium-derived hyperpolarizing factor in preeclampsia: heterogeneous contribution, mechanisms, and morphological prerequisites | Q46886600 | ||
| Interleukin-6 induces oxidative stress and endothelial dysfunction by overexpression of the angiotensin II type 1 receptor | Q30747560 | ||
| Antiplatelet agents for preventing and treating pre-eclampsia. | Q30867355 | ||
| [Ca(2+)](i) signaling in renal arterial smooth muscle cells of pregnant rat is enhanced during inhibition of NOS. | Q31732247 | ||
| Role of endothelin B receptors in enhancing endothelium-dependent nitric oxide-mediated vascular relaxation during high salt diet | Q32071788 | ||
| Maternal serum inhibin-A and activin-A levels in the first trimester of pregnancies developing pre-eclampsia | Q33371864 | ||
| Human genetic selection on the MTHFR 677C>T polymorphism | Q33387977 | ||
| Vascular and cellular calcium in normal and hypertensive pregnancy | Q33781354 | ||
| Fetal and maternal contributions to risk of pre-eclampsia: population based study | Q33783098 | ||
| Invasive cytotrophoblast apoptosis in pre-eclampsia | Q33848112 | ||
| Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor | Q33848380 | ||
| Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies | Q33930498 | ||
| Molecular regulation of the endothelin-1 gene by hypoxia. Contributions of hypoxia-inducible factor-1, activator protein-1, GATA-2, AND p300/CBP. | Q33940517 | ||
| ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. | Q33990220 | ||
| Disentangling fetal and maternal susceptibility for pre-eclampsia: a British multicenter candidate-gene study | Q34021020 | ||
| The extracellular matrix can regulate vascular cell migration, proliferation, and survival: relationships to vascular disease | Q34022649 | ||
| Placental growth factor is a potent vasodilator of rat and human resistance arteries. | Q34052025 | ||
| Genetic conflicts in human pregnancy | Q34060435 | ||
| Nitric oxide regulates the expression of vasoconstrictors and growth factors by vascular endothelium under both normoxia and hypoxia | Q34110398 | ||
| Hypoxia-inducible factor 1: control of oxygen homeostasis in health and disease | Q34236127 | ||
| Protein kinase C isoforms as specific targets for modulation of vascular smooth muscle function in hypertension | Q34293890 | ||
| Matrix metalloproteinases: they're not just for matrix anymore! | Q34360566 | ||
| Latest advances in understanding preeclampsia | Q34425288 | ||
| Angiotensin and cytoskeletal proteins: role in vascular remodeling | Q34492824 | ||
| Vitamins C and E and the risks of preeclampsia and perinatal complications | Q34518082 | ||
| Maternal vitamin D deficiency increases the risk of preeclampsia | Q34579840 | ||
| Deficiency in catechol-O-methyltransferase and 2-methoxyoestradiol is associated with pre-eclampsia | Q34656275 | ||
| Chymotrypsin-like protease (chymase) mediates endothelial activation by factors derived from preeclamptic placentas | Q34707016 | ||
| 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system | Q34793842 | ||
| Nutrient involvement in preeclampsia | Q35121229 | ||
| The genetics of pre-eclampsia: a feto-placental or maternal problem? | Q35177399 | ||
| HLA-G, pre-eclampsia, immunity and vascular events | Q35190892 | ||
| Subclassification of preeclampsia | Q35196220 | ||
| Molecular and biological properties of the vascular endothelial growth factor family of proteins | Q35313427 | ||
| The potential benefits of using fish oil in relation to preterm labor: the case for a randomized controlled trial? | Q35583130 | ||
| Autoantibody from women with preeclampsia induces soluble Fms-like tyrosine kinase-1 production via angiotensin type 1 receptor and calcineurin/nuclear factor of activated T-cells signaling | Q35681804 | ||
| Enhanced expression of Ang-(1-7) during pregnancy | Q35845564 | ||
| Abnormal placentation and the syndrome of preeclampsia | Q35941005 | ||
| Developmental biology of the placenta and the origins of placental insufficiency | Q36030154 | ||
| Angiotensin II and vascular inflammation. | Q36140047 | ||
| Preeclampsia: recent insights | Q36288757 | ||
| Could antioxidant supplementation prevent pre-eclampsia? | Q36325124 | ||
| New insights into the biology of preeclampsia | Q36371864 | ||
| Neurovascular mechanisms of hypertension in pregnancy | Q36486193 | ||
| Maternal serum soluble CD30 is increased in normal pregnancy, but decreased in preeclampsia and small for gestational age pregnancies | Q36512063 | ||
| Alternative complement pathway activation fragment Bb in early pregnancy as a predictor of preeclampsia | Q36618406 | ||
| Evidence of placental translation inhibition and endoplasmic reticulum stress in the etiology of human intrauterine growth restriction. | Q36778250 | ||
| The role of the immune system in preeclampsia | Q36791219 | ||
| Assignment of the vascular endothelial growth factor gene to human chromosome 6p21.3. | Q36796674 | ||
| Gestational diabetes, pregnancy hypertension, and late vascular disease | Q36862954 | ||
| The glomerular injury of preeclampsia | Q36883342 | ||
| Vascular endothelial growth factor is increased in patients with preeclampsia | Q36888688 | ||
| Low plasma levels of tissue factor pathway inhibitor in patients with congenital factor V deficiency. | Q36948563 | ||
| Prolonged increases in vein wall tension increase matrix metalloproteinases and decrease constriction in rat vena cava: Potential implications in varicose veins | Q36953739 | ||
| Preeclampsia and angiogenic imbalance | Q36971766 | ||
| Pathophysiology of hypertension during preeclampsia: linking placental ischemia with endothelial dysfunction | Q37022723 | ||
| Severe preeclampsia-related changes in gene expression at the maternal-fetal interface include sialic acid-binding immunoglobulin-like lectin-6 and pappalysin-2. | Q37072792 | ||
| Inflammatory cytokines in the pathophysiology of hypertension during preeclampsia | Q37119326 | ||
| Altered global gene expression in first trimester placentas of women destined to develop preeclampsia | Q37155561 | ||
| Differential [Ca2+]i signaling of vasoconstriction in mesenteric microvessels of normal and reduced uterine perfusion pregnant rats | Q37200099 | ||
| Susceptibility loci for preeclampsia on chromosomes 2p25 and 9p13 in Finnish families | Q37205410 | ||
| Increased sFlt-1 to PlGF ratio in women who subsequently develop preeclampsia | Q37221219 | ||
| Potential markers of preeclampsia--a review | Q37278804 | ||
| Searching for genetic factors underlying pre-eclampsia: recent progress and persistent challenges. | Q37293822 | ||
| Uric acid attenuates trophoblast invasion and integration into endothelial cell monolayers | Q37298028 | ||
| Maternal serum and amniotic fluid inhibin A levels in women who subsequently develop severe preeclampsia | Q37313333 | ||
| The uterine placental bed Renin-Angiotensin system in normal and preeclamptic pregnancy | Q37328814 | ||
| Soluble and membranous vascular endothelial growth factor receptor-2 in pregnancies complicated by pre-eclampsia | Q37400965 | ||
| The levels of leptin, adiponectin, and resistin in normal weight, overweight, and obese pregnant women with and without preeclampsia | Q47369214 | ||
| Weight loss regulates inflammation-related genes in white adipose tissue of obese subjects | Q47402001 | ||
| Trends in fetal and infant survival following preeclampsia | Q47578441 | ||
| Increased visfatin and leptin in pregnancies complicated by pre-eclampsia | Q47673405 | ||
| Association of -634G/C and 936C/T polymorphisms of the vascular endothelial growth factor with spontaneous preterm delivery | Q47836743 | ||
| First trimester maternal serum placental protein 13 for the prediction of pre-eclampsia in women with a priori high risk | Q47872838 | ||
| Endothelial dysfunction in preeclampsia | Q47879591 | ||
| Vascular contraction and preeclampsia: downregulation of the Angiotensin receptor 1 by hemopexin in vitro | Q47884975 | ||
| Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia | Q47915288 | ||
| Guidelines for the management of hypertensive disorders of pregnancy 2008. | Q48421837 | ||
| Calcium supplementation is associated with endothelium dependent attenuation of vascular smooth muscle reactivity in normotensive pregnant and nonpregnant rats. | Q50525147 | ||
| Systemic hemodynamic and regional blood flow changes in response to chronic reductions in uterine perfusion pressure in pregnant rats. | Q50952787 | ||
| Folic acid improves endothelial dysfunction in type 2 diabetes--an effect independent of homocysteine-lowering. | Q51493196 | ||
| Hypocalcemia and pregnancy-induced hypertension produced by low-calcium diet. | Q51594970 | ||
| Evaluation of metalloproteinases 2 and 9 and their inhibitors in physiologic and pre-eclamptic pregnancy. | Q51767630 | ||
| Relaxin is essential for systemic vasodilation and increased global arterial compliance during early pregnancy in conscious rats. | Q51793504 | ||
| Decreased serum levels of kisspeptin in early pregnancy are associated with intra-uterine growth restriction and pre-eclampsia. | Q51931004 | ||
| The importance of genetic and environmental effects for pre-eclampsia and gestational hypertension: a family study. | Q52003519 | ||
| Decidual NK cells regulate key developmental processes at the human fetal-maternal interface. | Q52010655 | ||
| Effective prediction of preeclampsia by a combined ratio of angiogenesis-related factors. | Q53538854 | ||
| Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. | Q53600812 | ||
| Neutrophil activation in pregnancy-induced hypertension. | Q53684496 | ||
| Cellular mRNA expressions of anti-oxidant factors in the blood of preeclamptic women. | Q54485033 | ||
| Increased levels of pregnancy-associated plasma protein-A2 in the serum of pre-eclamptic patients. | Q54515085 | ||
| Twin pregnancy and the risk of preeclampsia: bigger placenta or relative ischemia? | Q54551217 | ||
| Rho A/Rho kinase: human umbilical artery mRNA expression in normal and pre eclamptic pregnancies and functional role in isoprostane-induced vasoconstriction. | Q54594222 | ||
| Role of endothelin in mediating tumor necrosis factor-induced hypertension in pregnant rats. | Q54661322 | ||
| Performance of a panel of maternal serum markers in predicting preeclampsia at 11-15 weeks' gestation | Q56994317 | ||
| Fine mapping and SNP analysis of positional candidates at the preeclampsia susceptibility locus (PREG1) on chromosome 2 | Q57670256 | ||
| Maternal and fetal genetic factors account for most of familial aggregation of preeclampsia: A population-based Swedish cohort study | Q57697489 | ||
| Neutralization of Circulating Vascular Endothelial Growth Factor (VEGF) by Anti-VEGF Antibodies and Soluble VEGF Receptor 1 (sFlt-1) Induces Proteinuria | Q58214894 | ||
| Neutrophil function in women with pre-eclampsia | Q59367361 | ||
| L-Arginine Supplementation in Patients with Gestational Hypertension: A Pilot Study | Q60690363 | ||
| Neutrophil activation in preeclampsia and isolated intrauterine growth restriction | Q60947615 | ||
| A Vascular Endothelial Growth Factor Antagonist Is Produced by the Human Placenta and Released into the Maternal Circulation1 | Q61479346 | ||
| Hypoxia-Inducible Factor-1 (HIF-1) | Q61645733 | ||
| First-trimester maternal serum pregnancy-associated plasma protein-A and pre-eclampsia | Q61826563 | ||
| Polymorphisms of FAS and FAS ligand genes in preeclamptic women | Q61851339 | ||
| Plasma level of soluble c-Met is tightly associated with the clinical risk of preeclampsia | Q61964340 | ||
| Plasma endothelin levels in preeclampsia: elevation and correlation with uric acid levels and renal impairment | Q68053902 | ||
| T cell awareness of paternal alloantigens during pregnancy | Q71768391 | ||
| Risk factors for severe preeclampsia | Q72291387 | ||
| Plasma nitric oxide metabolites and lipid peroxide levels in preeclamptic pregnant women before and after delivery | Q73258662 | ||
| Synergistic interaction between thromboxane A2 and mildly oxidized low density lipoproteins on vascular smooth muscle cell proliferation | Q73334865 | ||
| Pregnancy-associated reduction in vascular protein kinase C activity rebounds during inhibition of NO synthesis | Q73426782 | ||
| P433 | issue | 4 | |
| P921 | main subject | maternal health | Q6786626 |
| pre-eclampsia | Q61335 | ||
| P304 | page(s) | 204-226 | |
| P577 | publication date | 2010-10-01 | |
| P1433 | published in | Cardiovascular & hematological agents in medicinal chemistry | Q27721058 |
| P1476 | title | Molecular and vascular targets in the pathogenesis and management of the hypertension associated with preeclampsia | |
| P478 | volume | 8 |
| Q35813964 | A Proposed Molecular Mechanism of High-Dose Vitamin D3 Supplementation in Prevention and Treatment of Preeclampsia. |
| Q33665037 | Altered matrix metalloproteinase-2 and -9 expression/activity links placental ischemia and anti-angiogenic sFlt-1 to uteroplacental and vascular remodeling and collagen deposition in hypertensive pregnancy |
| Q28083815 | Bioactive factors in uteroplacental and systemic circulation link placental ischemia to generalized vascular dysfunction in hypertensive pregnancy and preeclampsia |
| Q46317860 | Correlations between circulating levels of adipokines and anti-angiogenic factors in women with BMI <30 and a late-onset preeclampsia |
| Q51000408 | Decreased homodimerization and increased TIMP-1 complexation of uteroplacental and uterine arterial matrix metalloproteinase-9 during hypertension-in-pregnancy. |
| Q37318884 | Enhanced endothelin receptor type B-mediated vasodilation and underlying [Ca²⁺]i in mesenteric microvessels of pregnant rats |
| Q36340302 | Epicardial fat tissue thickness in preeclamptic and normal pregnancies |
| Q38640174 | Functional IGF1R variant predicts breast cancer risk in women with preeclampsia in California Teachers Study |
| Q45879845 | Hemodynamic correlates of low umbilical cord vitamin D and ionized calcium |
| Q36793344 | Immunomodulatory role of vitamin D in the pathogenesis of preeclampsia |
| Q38720237 | Increased vascular and uteroplacental matrix metalloproteinase-1 and -7 levels and collagen type I deposition in hypertension in pregnancy: role of TNF-α. |
| Q96431729 | Independent influences of maternal obesity and fetal sex on maternal cardiovascular adaptation to pregnancy: a prospective cohort study |
| Q37686924 | Involvement of miRNAs in placental alterations mediated by oxidative stress. |
| Q50597564 | Is the level of maternal serum prohepcidin associated with preeclampsia? |
| Q35956397 | Lack of Thromboxane Synthase Prevents Hypertension and Fetal Growth Restriction after High Salt Treatment during Pregnancy |
| Q37194320 | Maternal plasma miRNAs expression in preeclamptic pregnancies |
| Q46342648 | Matrix Metalloproteinases in Normal Pregnancy and Preeclampsia |
| Q47223491 | Matrix Metalloproteinases, Vascular Remodeling, and Vascular Disease |
| Q37136212 | Mechanisms of Endothelial Dysfunction in Hypertensive Pregnancy and Preeclampsia |
| Q58589187 | Molecular Determinants of Microvascular Dysfunction in Hypertensive Pregnancy and Preeclampsia |
| Q93156154 | Molecular Targets of Aspirin and Prevention of Preeclampsia and Their Potential Association with Circulating Extracellular Vesicles during Pregnancy |
| Q36105461 | Molecular mechanisms regulating the vascular prostacyclin pathways and their adaptation during pregnancy and in the newborn |
| Q38804461 | PTH and Vitamin D. |
| Q42716832 | Pro-inflammatory role of angiotensin II in mercuric chloride-induced nephropathy in rats |
| Q26828020 | Role of endothelin in uteroplacental circulation and fetal vascular function |
| Q36984404 | The effect of allopurinol on lowering blood pressure in hemodialysis patients with hyperuricemia |
| Q28392215 | The effects of oxidative stress on female reproduction: a review |
| Q47645647 | The prediction of fetal death with a simple maternal blood test at 20-24 weeks: a role for angiogenic index-1 (PlGF/sVEGFR-1 ratio). |
| Q37651300 | The relationship of a family history for hypertension, myocardial infarction, or stroke with cardiovascular physiology in young women |
| Q37699594 | The risk factors for failure of labor induction: a cohort study. |
| Q35751236 | The role of cytokines as inflammatory mediators in preeclampsia |
| Q39039141 | Tumor Necrosis Factor-Alpha and Pregnancy: Focus on Biologics. An Updated and Comprehensive Review |
| Q51339686 | Uteroplacental insufficiency programmes vascular dysfunction in non-pregnant rats: compensatory adaptations in pregnancy. |
| Q47103299 | Vitamin D Enhances Efficacy of Oral Nifedipine in Treating Preeclampsia with Severe Features: A Double Blinded, Placebo-Controlled and Randomized Clinical Trial |
| Q46322246 | Vitamin D receptor polymorphisms in hypertensive disorders of pregnancy |
Search more.